GameStop Shares Dip Premarket After Monday’s 12.1% Slumpby Mark Eisenberg 18.06.2024GameStop shares dip again amid declining sales, CEO's profit-boosting store cuts, unclear $4B cash plan, and ongoing meme stock influence.
Apple Stock Cut at Phillip Capital Despite Target Hikeby Mark Eisenberg 18.06.2024"Phillip Capital adjusts Apple stock rating to 'Neutral' from 'Accumulate'; target price raised to $220 due to recent price rally ...
Blackstone’s $1.7B Bid for Japan’s Infocom: Teijin to Sell Stakeby Mark Eisenberg 18.06.2024Blackstone launches a $1.74B bid to take Infocom private; Teijin to sell its 58% stake, registering a 105B yen profit. ...
Jim Cramer’s Market Wisdom: Fundamentals Over Stock Noiseby Mark Eisenberg 18.06.2024Jim Cramer advises investors to ignore market "noise" and focus on company fundamentals rather than reacting to sudden stock moves.
Enphase EVP Sells $616K in Stock Amid High Valuationby Mark Eisenberg 18.06.2024Enphase Energy EVP sells $600k in stock; Insider transactions may signal personal planning or insights into company’s future. Analyst updates ...
Autodesk’s Blum Sells $3.9M in Shares Amid Market Movementsby Mark Eisenberg 18.06.2024Autodesk COO Steven Blum sells shares worth over $3.9M as part of a trading plan; retains 54,136 shares; Autodesk reports ...
Morocco Stocks Dip: All Shares Index Down 0.20%by Mark Eisenberg 17.06.2024Morocco stocks fell with the Moroccan All Shares index down 0.20%. Key stocks saw mixed results while commodity prices showed ...
Stock Splits and AI: Navigating the Future of Investmentsby Mark Eisenberg 17.06.2024Exploring AI's role in education: A college student reveals AI is banned for paper writing, with institutions using tools to ...
Nexalin Technology vs. Rivals: Volatility & Ownership Insightsby Mark Eisenberg 16.06.2024Nexalin Technology: 0.7% institutional, 7% insider ownership. Beta of 5.13 reveals high volatility; rivals surpass in 8 of 10 factors. ...
Jinyu Bio-technology’s 25% Plunge: Should Investors Worry?by Mark Eisenberg 16.06.2024Free report offers insights; earnings growth disappointing for Jinyu Bio-technology. Conditions may keep share price steady. Feedback welcomed.